Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0001281084 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 06/25/2026 false 0001009759 14067D607 Capstone Energy+, Inc. 16640 STAGG STREET VAN NUYS CA 91406 Colin J. Daniels, Esq. (212) 554-1700 Monarch Alternative Capital LP 535 Madison Avenue New York NY 10022 0001281084 N Monarch Alternative Capital LP b OO N DE 0.00 19333334.00 0.00 19333334.00 19333334.00 N 40.1 IA PN IA, PN 0001501101 N MDRA GP LP b OO N DE 0.00 19333334.00 0.00 19333334.00 19333334.00 N 40.1 HC PN PN, HC 0001501100 N Monarch GP LLC b OO N DE 0.00 19333334.00 0.00 19333334.00 19333334.00 N 40.1 HC OO OO, HC Common Stock, par value $0.001 per share Capstone Energy+, Inc. 16640 STAGG STREET VAN NUYS CA 91406 The following constitutes Amendment No. 1 to the Schedule 13D filed by the undersigned ("Amendment No. 1"). This Amendment No. 1 amends the Schedule 13D as specifically set forth herein. This Amendment No. 1 was triggered solely due to a change in the number of outstanding Shares of the Issuer. The information contained on the cover pages of this Schedule 13D is incorporated into this Item 5 by reference. The number of shares of Common Stock beneficially owned by the Reporting Persons remains unchanged from the initial Schedule 13D filed by the Reporting Persons and consists of 3,333,334 shares of Common Stock and 16,000,000 shares of Common Stock issuable upon conversion of the Series A Preferred Stock at the initial Conversion Price. This Amendment No. 1 is being filed to update the percentage of beneficial ownership reported by the Reporting Persons, which decreased solely as a result of an increase in the number of outstanding shares of Common Stock reported by the Issuer since the filing of the initial Schedule 13D. The percentages used in this Amendment are calculated based upon 32,230,733 shares of Common Stock outstanding as of June 18, 2026, as reported in the Annual Report on Form 10-K filed by the Issuer with the SEC on June 25, 2026, plus 16,000,000 shares of Common Stock issuable upon conversion of the Series A Preferred Stock beneficially owned by the Reporting Persons at the initial Conversion Price. Except for the change in the Reporting Persons' percentage of beneficial ownership resulting from the increase in the number of outstanding shares of Common Stock reported by the Issuer, there has been no change in the number of shares of Common Stock or Series A Preferred Stock beneficially owned by the Reporting Persons as reported in the initial Schedule 13D. The information contained on the cover pages of this Schedule 13D is incorporated into this Item 5 by reference. The number of shares of Common Stock beneficially owned by the Reporting Persons remains unchanged from the initial Schedule 13D filed by the Reporting Persons and consists of 3,333,334 shares of Common Stock and 16,000,000 shares of Common Stock issuable upon conversion of the Series A Preferred Stock at the initial Conversion Price. This Amendment No. 1 is being filed to update the percentage of beneficial ownership reported by the Reporting Persons, which decreased solely as a result of an increase in the number of outstanding shares of Common Stock reported by the Issuer since the filing of the initial Schedule 13D. The percentages used in this Amendment are calculated based upon 32,230,733 shares of Common Stock outstanding as of June 18, 2026, as reported in the Annual Report on Form 10-K filed by the Issuer with the SEC on June 25, 2026, plus 16,000,000 shares of Common Stock issuable upon conversion of the Series A Preferred Stock beneficially owned by the Reporting Persons at the initial Conversion Price. Except for the change in the Reporting Persons' percentage of beneficial ownership resulting from the increase in the number of outstanding shares of Common Stock reported by the Issuer, there has been no change in the number of shares of Common Stock or Series A Preferred Stock beneficially owned by the Reporting Persons as reported in the initial Schedule 13D. The Reporting Persons have not effected any transactions in the Common Stock during the past sixty (60) days. Monarch Alternative Capital LP /s/ Andrew Herenstein Andrew Herenstein/Vice Chairman 06/29/2026 MDRA GP LP Monarch GP LLC General Partner 06/29/2026 /s/ Andrew Herenstein Andrew Herenstein/Authorized Person 06/29/2026 Monarch GP LLC /s/ Andrew Herenstein Andrew Herenstein/Authorized Person 06/29/2026